1. Home
  2. BOXL vs ZVSA Comparison

BOXL vs ZVSA Comparison

Compare BOXL & ZVSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOXL
  • ZVSA
  • Stock Information
  • Founded
  • BOXL 1985
  • ZVSA 2014
  • Country
  • BOXL United States
  • ZVSA United States
  • Employees
  • BOXL N/A
  • ZVSA N/A
  • Industry
  • BOXL Telecommunications Equipment
  • ZVSA Biotechnology: Pharmaceutical Preparations
  • Sector
  • BOXL Telecommunications
  • ZVSA Health Care
  • Exchange
  • BOXL Nasdaq
  • ZVSA Nasdaq
  • Market Cap
  • BOXL 3.3M
  • ZVSA 3.5M
  • IPO Year
  • BOXL 2017
  • ZVSA N/A
  • Fundamental
  • Price
  • BOXL $1.43
  • ZVSA $0.62
  • Analyst Decision
  • BOXL Buy
  • ZVSA Strong Buy
  • Analyst Count
  • BOXL 2
  • ZVSA 1
  • Target Price
  • BOXL $5.00
  • ZVSA $240.00
  • AVG Volume (30 Days)
  • BOXL 24.7K
  • ZVSA 125.6K
  • Earning Date
  • BOXL 05-07-2025
  • ZVSA 05-14-2025
  • Dividend Yield
  • BOXL N/A
  • ZVSA N/A
  • EPS Growth
  • BOXL N/A
  • ZVSA N/A
  • EPS
  • BOXL N/A
  • ZVSA N/A
  • Revenue
  • BOXL $135,893,000.00
  • ZVSA N/A
  • Revenue This Year
  • BOXL $3.88
  • ZVSA N/A
  • Revenue Next Year
  • BOXL $2.80
  • ZVSA N/A
  • P/E Ratio
  • BOXL N/A
  • ZVSA N/A
  • Revenue Growth
  • BOXL N/A
  • ZVSA N/A
  • 52 Week Low
  • BOXL $1.36
  • ZVSA $0.58
  • 52 Week High
  • BOXL $10.65
  • ZVSA $8.05
  • Technical
  • Relative Strength Index (RSI)
  • BOXL 40.16
  • ZVSA 33.63
  • Support Level
  • BOXL $1.41
  • ZVSA $0.69
  • Resistance Level
  • BOXL $1.56
  • ZVSA $0.65
  • Average True Range (ATR)
  • BOXL 0.11
  • ZVSA 0.06
  • MACD
  • BOXL 0.05
  • ZVSA 0.00
  • Stochastic Oscillator
  • BOXL 18.60
  • ZVSA 26.73

About BOXL Boxlight Corporation

Boxlight Corp is a technology company that develops, sells and services interactive solutions predominantly for the education market, but also for the corporates and government sectors. The company currently designs, produces and distributes interactive technologies including interactive and non-interactive flat panel displays, LED video walls, media players, classroom audio and campus communication, cameras and other peripherals for the education market and non-interactive solutions including flat panels, LED video walls and digital signage. The company also distributes science, technology, engineering and math (or STEM) products, including 3D printing and robotics solutions, and a portable science lab.

About ZVSA ZyVersa Therapeutics Inc.

ZyVersa Therapeutics Inc is a clinical-stage biopharmaceutical company leveraging proprietary technologies to develop drugs for patients with chronic renal or inflammatory diseases with high unmet medical needs. The company has two proprietary globally licensed drug development platforms which are Cholesterol Efflux MediatorTM, VAR 200 (2-hydroxypropyl-beta-cyclodextrin) is an injectable drug in clinical development for the treatment of renal diseases. and IC 100 is a monoclonal antibody inflammasome ASC inhibitor in preclinical development for the treatment of inflammatory conditions.

Share on Social Networks: